{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:14:05Z","timestamp":1772234045645,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1208\/s12248-021-00617-6","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T16:02:55Z","timestamp":1623772975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of Microparticulate (S)-4,5-Dihydroxy-2,3-pentanedione (DPD) as a Potential Vaccine Adjuvant"],"prefix":"10.1208","volume":"23","author":[{"given":"Devyani","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Chbib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad N.","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"617_CR1","doi-asserted-by":"crossref","unstructured":"Edelman R. The development and use of vaccine adjuvants [Internet]. In: Vol. 21, Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology: Springer; 2002. p. 129\u201348. [cited 2020 Nov 29]. Available from: https:\/\/link.springer.com\/article\/10.1385\/MB:21:2:129.","DOI":"10.1385\/MB:21:2:129"},{"issue":"6","key":"617_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1023\/A:1016104910582","volume":"19","author":"M Singh","year":"2002","unstructured":"Singh M, O\u2019Hagan DT. Recent advances in vaccine adjuvants. Pharm Res. 2002;19(6):715\u201328.","journal-title":"Pharm Res"},{"key":"617_CR3","unstructured":"Adjuvant | Definition of Adjuvant by Merriam-Webster [Internet]. [cited 2020 Nov 29]. Available from: https:\/\/www.merriam-webster.com\/dictionary\/adjuvant"},{"issue":"19","key":"617_CR4","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","volume":"25","author":"JC Aguilar","year":"2007","unstructured":"Aguilar JC, Rodr\u00edguez EG. Vaccine adjuvants revisited. Vaccine. 2007;25(19):3752\u201362.","journal-title":"Vaccine."},{"key":"617_CR5","doi-asserted-by":"crossref","unstructured":"Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work [Internet]. In: Vol. 33, Immunity. Immunity; 2010. p. 492\u2013503. [cited 2020 Nov 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21029960\/.","DOI":"10.1016\/j.immuni.2010.10.002"},{"key":"617_CR6","volume-title":"An overview of immunologic adjuvants - a review","author":"AP Harini","year":"2013","unstructured":"Harini AP, Kumar AH, Praveen Kumar G, Neeta S. An overview of immunologic adjuvants - a review. 2013"},{"issue":"4","key":"617_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/btpr.10","volume":"24","author":"KS Jones","year":"2008","unstructured":"Jones KS. Biomaterials as vaccine adjuvants. Biotechnol Prog [Internet]. 2008;24(4):807\u201314 [cited 2020 Nov 29] Available from: http:\/\/doi.wiley.com\/10.1002\/btpr.10.","journal-title":"Biotechnol Prog [Internet]"},{"key":"617_CR8","doi-asserted-by":"crossref","unstructured":"Mallapragada SK, Narasimhan B. Immunomodulatory biomaterials. Vol. 364, International Journal of Pharmaceutics. Elsevier; 2008. p. 265\u201371","DOI":"10.1016\/j.ijpharm.2008.06.030"},{"key":"617_CR9","doi-asserted-by":"crossref","unstructured":"Oyewumi MO, Kumar A, Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses [Internet]. In: Vol. 9, Expert Review of Vaccines: NIH Public Access; 2010. p. 1095\u2013107. [cited 2020 Nov 29] Available from: \/pmc\/articles\/PMC2963573\/?report=abstract.","DOI":"10.1586\/erv.10.89"},{"issue":"2","key":"617_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1586\/14760584.2.2.269","volume":"2","author":"DT O\u2019Hogan","year":"2003","unstructured":"O\u2019Hogan DT, Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines. 2003;2(2):269\u201383.","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"617_CR11","first-page":"239","volume":"73","author":"DT O\u2019Hagan","year":"1991","unstructured":"O\u2019Hagan DT, Rahman D, McGee JP, Jeffery H, Davies MC, Williams P, et al. Biodegradable microparticles as controlled release antigen delivery systems. Immunology [Internet]. 1991;73(2):239\u201342 [cited 2020 Nov 29] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2071168.","journal-title":"Immunology [Internet]"},{"issue":"10","key":"617_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/0264-410X(91)90295-H","volume":"9","author":"DT O\u2019Hagan","year":"1991","unstructured":"O\u2019Hagan DT, Jeffery H, Roberts MJJ, McGee JP, Davis SS. Controlled release microparticles for vaccine development. Vaccine. 1991 Oct 1;9(10):768\u201371.","journal-title":"Vaccine."},{"issue":"4S","key":"617_CR13","doi-asserted-by":"publisher","first-page":"s63","DOI":"10.1038\/nm1210","volume":"11","author":"A Pashine","year":"2005","unstructured":"Pashine A, Valiante NM, Ulmer JB. Targeting the innate immune response with improved vaccine adjuvants. Nat Med [Internet]. 2005;11(4S):s63 [cited 2020 Nov 29] Available from: http:\/\/www.nature.com\/naturemedicine.","journal-title":"Nat Med [Internet]"},{"issue":"16","key":"617_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0264-410X(96)00099-0","volume":"14","author":"DF Nixon","year":"1996","unstructured":"Nixon DF, Hioe C, De Chen P, Bian Z, Kuebler P, Li ML, et al. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine [Internet]. 1996;14(16):1523\u201330 [cited 2020 Nov 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/9014294\/.","journal-title":"Vaccine [Internet]"},{"issue":"9","key":"617_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/0264-410X(93)90387-D","volume":"11","author":"DT O\u2019Hagan","year":"1993","unstructured":"O\u2019Hagan DT, Jeffery H, Davis SS. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine. 1993;11(9):965\u20139.","journal-title":"Vaccine."},{"issue":"4","key":"617_CR16","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1073\/pnas.96.4.1639","volume":"96","author":"MG Surette","year":"1999","unstructured":"Surette MG, Miller MB, Bassler BL. Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc Natl Acad Sci U S A [Internet]. 1999;96(4):1639\u201344 [cited 2020 Nov 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/9990077\/.","journal-title":"Proc Natl Acad Sci U S A [Internet]"},{"key":"617_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.cellbio.21.012704.131001","volume":"21","author":"CM Waters","year":"2005","unstructured":"Waters CM, Bassler BL. Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol. 2005;21:319\u201346.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"617_CR18","doi-asserted-by":"crossref","unstructured":"Bassler BL, Losick R. Bacterially speaking [Internet]. Cell. 2006;125:237\u201346 [cited 2020 Nov 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16630813\/.","DOI":"10.1016\/j.cell.2006.04.001"},{"issue":"7","key":"617_CR19","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1039\/b702781h","volume":"37","author":"CA Lowery","year":"2008","unstructured":"Lowery CA, Dickerson TJ, Janda KD. Interspecies and interkingdom communication mediated by bacterial quorum sensing. Chem Soc Rev. 2008;37(7):1337\u201346.","journal-title":"Chem Soc Rev"},{"key":"617_CR20","doi-asserted-by":"crossref","unstructured":"Ng WL, Bassler BL. Bacterial quorum-sensing network architectures [Internet]. Vol. 43, Annual Review of Genetics. Annu Rev Genet. 2009:197\u2013222 [cited 2020 Nov 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19686078\/.","DOI":"10.1146\/annurev-genet-102108-134304"},{"key":"617_CR21","doi-asserted-by":"crossref","unstructured":"Stotani S, Gatta V, Medda F, Padmanaban M, Karawajczyk A, Tammela P, et al. A versatile strategy for the synthesis of 4,5-dihydroxy-2,3-pentanedione (DPD) and related compounds as potential modulators of bacterial quorum sensing. Molecules. 2018;23(10).","DOI":"10.3390\/molecules23102545"},{"issue":"29","key":"617_CR22","doi-asserted-by":"publisher","first-page":"9200","DOI":"10.1021\/ja802353j","volume":"130","author":"CA Lowery","year":"2008","unstructured":"Lowery CA, Park J, Kaufmann GF, Janda KD. An unexpected switch in the modulation of AI-2-based quorum sensing discovered through synthetic 4,5-dihydroxy-2,3-pentanedione analogues. J Am Chem Soc [Internet]. 2008;130(29):9200\u20131 [cited 2020 Nov 29] Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2668569\/.","journal-title":"J Am Chem Soc [Internet]"},{"issue":"20","key":"617_CR23","doi-asserted-by":"publisher","first-page":"19563","DOI":"10.1074\/jbc.M412660200","volume":"280","author":"SCJ De Keersmaeckert","year":"2005","unstructured":"De Keersmaeckert SCJ, Varszegi C, Van Boxel N, Habel LW, Metzger K, Daniels R, et al. Chemical synthesis of (S)-4,5-dihydroxy-2,3-pentanedione, a bacterial signal molecule precursor, and validation of its activity in Salmonella typhimurium. J Biol Chem [Internet]. 2005;280(20):19563\u20138 [cited 2020 Nov 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15790567\/.","journal-title":"J Biol Chem [Internet]"},{"key":"617_CR24","doi-asserted-by":"crossref","unstructured":"Rutherford ST, Bassler BL. Bacterial quorum sensing: its role in virulence and possibilities for its control [Internet]. Vol. 2, Cold Spring Harbor Perspectives in Medicine. Cold Spring Harbor Laboratory Press. 2012; [cited 2020 Nov 29]. Available from: \/pmc\/articles\/PMC3543102\/?report=abstract.","DOI":"10.1101\/cshperspect.a012427"},{"issue":"3","key":"617_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/vaccines6030060","volume":"6","author":"R Gala","year":"2018","unstructured":"Gala R, Zaman R, D\u2019Souza M, Zughaier S. Novel whole-cell inactivated Neisseria gonorrhoeae microparticles as vaccine formulation in microneedle-based transdermal immunization. Vaccines [Internet]. 2018;6(3):60 [cited 2020 Nov 29] Available from: http:\/\/www.mdpi.com\/2076-393X\/6\/3\/60.","journal-title":"Vaccines [Internet]"},{"issue":"4","key":"617_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/02652048.2011.651503","volume":"29","author":"L Chablani","year":"2012","unstructured":"Chablani L, Tawde SA, D\u2019Souza MJ. Spray-dried microparticles: a potential vehicle for oral delivery of vaccines. J Microencapsul. 2012;29(4):388\u201397.","journal-title":"J Microencapsul"},{"issue":"2","key":"617_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1208\/s12249-016-0566-3","volume":"18","author":"RP Gala","year":"2017","unstructured":"Gala RP, Popescu C, Knipp GT, McCain RR, Ubale RV, Addo R, et al. Physicochemical and preclinical evaluation of a novel buccal measles vaccine. AAPS PharmSciTech [Internet]. 2017;18(2):283\u201392. https:\/\/doi.org\/10.1208\/s12249-016-0566-3.","journal-title":"AAPS PharmSciTech [Internet]"},{"key":"617_CR28","first-page":"1393","volume":"8","author":"GG Enriquez","year":"2013","unstructured":"Enriquez GG, Rizvi SAA, D\u2019Souza MJ, Do DP. Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy. Int J Nanomedicine [Internet]. 2013;8:1393\u2013402 [cited 2021 May 3] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23630421\/.","journal-title":"Int J Nanomedicine [Internet]"},{"issue":"28","key":"617_CR29","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1016\/j.vaccine.2016.05.010","volume":"34","author":"RP Gala","year":"2016","unstructured":"Gala RP, D\u2019Souza M, Zughaier SM. Evaluation of various adjuvant nanoparticulate formulations for meningococcal capsular polysaccharide-based vaccine. Vaccine [Internet]. 2016;34(28):3260\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.010.","journal-title":"Vaccine [Internet]"},{"issue":"2","key":"617_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/1061186X.2011.622395","volume":"20","author":"B D\u2019Souza","year":"2012","unstructured":"D\u2019Souza B, Bhowmik T, Shashidharamurthy R, Oettinger C, Selvaraj P, D\u2019Souza M. Oral microparticulate vaccine for melanoma using M-cell targeting. J Drug Target. 2012;20(2):166\u201373.","journal-title":"J Drug Target"},{"issue":"4","key":"617_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1574-6976.2001.tb00583.x","volume":"25","author":"NA Whitehead","year":"2001","unstructured":"Whitehead NA, Barnard AML, Slater H, Simpson NJL, GPC S. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev [Internet]. 2001;25(4):365\u2013404 [cited 2020 Nov 29] Available from: www.fems-microbiology.org.","journal-title":"FEMS Microbiol Rev [Internet]"},{"issue":"1\u20134","key":"617_CR32","first-page":"233","volume":"81","author":"MHJ Sturme","year":"2002","unstructured":"Sturme MHJ, Kleerebezem M, Nakayama J, Akkermans ADL, Vaughan EE, De Vos WM. Cell to cell communication by autoinducing peptides in gram-positive bacteria. Antonie van Leeuwenhoek. Int J Gen Mol Microbiol [Internet]. 2002;81(1\u20134):233\u201343 Available from: [cited 2020 Nov 29] https:\/\/link.springer.com\/article\/10.1023\/A:1020522919555.","journal-title":"Int J Gen Mol Microbiol [Internet]"},{"key":"617_CR33","unstructured":"World Health Organization. Guidelines on the nonclinical evaluation of vaccine adjuvants and adjuvanted vaccines. WHO Press [Internet]. 2013:56 Available from: https:\/\/www.who.int\/biologicals\/areas\/vaccines\/ADJUVANTS_Post_ECBS_edited_clean_Guidelines_NCE_Adjuvant_Final_17122013_WEB.pdf."},{"key":"617_CR34","doi-asserted-by":"crossref","unstructured":"Storni T, K\u00fcndig TM, Senti G, Johansen P. Immunity in response to particulate antigen-delivery systems [Internet]. Vol. 57, Advanced Drug Delivery Reviews. Elsevier B.V.; 2005 [cited 2020 Jun 19]. p. 333\u201355. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X04002066.","DOI":"10.1016\/j.addr.2004.09.008"},{"key":"617_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.drudis.2011.04.006","volume":"16","author":"ML De Temmerman","year":"2011","unstructured":"De Temmerman ML, Rejman J, Demeester J, Irvine DJ, Gander B, De Smedt SC. Particulate vaccines: on the quest for optimal delivery and immune response [Internet]. Drug Discov Today. 2011;16:569\u201382 [cited 2020 Jun 19] Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644611001334.","journal-title":"Drug Discov Today"},{"issue":"3","key":"617_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/009841096161807","volume":"47","author":"SLP Jordan","year":"1996","unstructured":"Jordan SLP, Russo MR, Blessing RL, Theis AB. Inactivation of glutaraldehyde by reaction with sodium bisulfite. J Toxicol Environ Heal - Part A [Internet]. 1996;47(3):299\u2013309 [cited 2021 May 3] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/8604152\/.","journal-title":"J Toxicol Environ Heal - Part A [Internet]"},{"key":"617_CR37","doi-asserted-by":"crossref","unstructured":"Migneault I, Dartiguenave C, Bertrand MJ, Waldron KC. Glutaraldehyde: behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking [Internet]. Vol. 37, BioTechniques. Eaton Publishing Company; 2004 [cited 2021 May 3]. p. 790\u2013802. Available from: https:\/\/www.future-science.com\/doi\/abs\/10.2144\/04375RV01","DOI":"10.2144\/04375RV01"},{"issue":"46","key":"617_CR38","doi-asserted-by":"publisher","first-page":"2002990","DOI":"10.1002\/adma.202002990","volume":"32","author":"A Ukidve","year":"2020","unstructured":"Ukidve A, Cu K, Goetz M, Angsantikul P, Curreri A, Tanner EEL, et al. Ionic-liquid-based safe adjuvants. Adv Mater [Internet]. 2020;32(46):2002990 [cited 2020 Nov 29] Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/adma.202002990.","journal-title":"Adv Mater [Internet]"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-021-00617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-021-00617-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-021-00617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T15:21:30Z","timestamp":1629300090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-021-00617-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1208\/s12248-021-00617-6","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors alone are responsible for the contents and writing of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"84"}}